Filter
365
Filtered Results: 365
Text search:
Yu,
J.
et
al.
Featured
Recommendations
45
New Publications
30
Language
Document type
Guidelines
109
No document type
106
Studies & Reports
96
Manuals
24
Fact sheets
17
Strategic & Response Plan
9
Training Material
1
Situation Updates
1
Resource Platforms
1
Infographics
1
Countries / Regions
Brazil
22
Russia
22
Global
14
Latin America and the Carribbean
11
Germany
11
South Africa
8
Spain
7
Mozambique
6
Middle East and North Africa
6
Ukraine
5
Philippines
5
Argentina
5
Syria
4
Asia
4
Western and Central Europe
4
Vietnam
4
Yemen
4
Angola
4
Colombia
3
Kenya
3
China
3
Peru
3
Africa
3
Eastern Europe and Central Asia
3
Portugal
3
Eastern Europe
3
Ecuador
3
India
3
Ghana
2
Nigeria
2
Italy
2
Guinea-Bissau
2
West and Central Africa
2
South–East Asia Region
2
Western Pacific Region
2
France
2
East and Southern Africa
2
Uganda
2
Tajikistan
1
Switzerland
1
Lesotho
1
Turkey
1
Chile
1
Cameroon
1
Laos
1
Senegal
1
Burkina Faso
1
Malawi
1
Zimbabwe
1
Austria
1
Cambodia
1
Tanzania
1
Jordan
1
Congo, Democratic Republic of
1
Paraguay
1
United Kingdom
1
Lebanon
1
Sudan
1
Mali
1
Botswana
1
South Sudan
1
Indonesia
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
113
Clinical Guidelines
23
Public Health
21
Women & Child Health
8
Key Resources
6
Pharmacy & Technologies
6
Capacity Building
1
Toolboxes
COVID-19
130
Mental Health
35
HIV
25
Planetary Health
23
TB
22
Disability
15
AMR
14
NCDs
13
Ebola
9
Pharmacy
9
NTDs
8
Rapid Response
7
Refugee
7
Caregiver
7
Health Financing Toolbox
3
Zika
2
Polio
2
Natural Hazards
1
Cholera
1
Global Health Education
1
Guidelines on Management of COVID-19 in Kenya
recommended
It has been over a year since Kenya identified the first case of COVID-19 in the country. The Government formed the National COVID-19 task force, which supported the country's response through multi-sectoral technical working groups on testing, case management, risk communication and community engag...
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19)
Interim guidance 19 July 2021
O SAGE aplica os princípios da medicina baseada em evidências e estabeleceu um processo metodológico completo para emitir ou atualizar recomendações. Especificamente para vacinas contra a COVID-19, uma descrição detalhada dos processos metodológicos pode ser encontrada no esquema de evidênc...
In this edition, the Antimicrobial Resistance chapter discusses the growing, dangerous trend of antimicrobial resistance and the potential catastrophic consequences on global health.
Chapter 1 of Frontier 2017: Emerging Issues of Environmental Concern
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most of these diseases and conditions are at least partially cau...
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact ...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
Update, 23 de junio de 2022
This document, Programme and curriculum development guide, presents a systematic approach to developing programmes and curricula for implementation of the family planning (FP) and comprehensive abortion care (CAC) competencies,and the theory behind the approach. Specifically, the aim is for effectiv...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
Myocardial infarctions are generally clinically classified into ST elevation MI (STEMI) and non-ST elevation MI (NSTEMI), based on changes in ECG. When blood flow to a part of the heart stops or the heart is injured and fails to receive enough oxygen required for its adequate functioning the conditi...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
The document "Global Report on Diabetes" by the World Health Organization (WHO) provides an in-depth analysis of diabetes as a global health challenge. It covers the rising prevalence of the disease, the associated risk factors, and the increasing burden on healthcare systems, particularly in low- a...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
The Implementation toolkit for accessible telehealth services provides practical guidance to support governments, industry partners, health service providers and civil society groups in the use and implementation of the WHO-ITU Global standard for accessibility of telehealth services. The toolkit is...
interim guidance, 25 November 2024
World Drug Report 2017
-5-
Accessed: 14.03.2019
Diese Faktenboxen sollen Ihnen helfen, Nutzen und Schaden einer Schutzimpfung gegen COVID-19 abzuwägen. Die Informationen und Zahlen stellen keine endgültige Bewertung dar. Sie basieren auf den derzeit besten wissenschaftlichen Erkenntnissen.
